AI Made Friendly HERE

How AI is supercharging clinical trials

Artificial intelligence (AI) and machine learning are here to stay, so it’s crucial to understand how they can be used to the best effect in the evolving world of clinical trials.

From patient identification and recruitment, to protocol development and design, and to trial monitoring and data analysis, AI can improve the effectiveness of current clinical trials in myriad ways for a variety of stakeholders. As this technology proliferates, those who don’t adopt AI systems, or don’t implement them in the right way, will fall behind their competitors. How can sponsors, investigators, and clinical trial sites best position themselves in this rapidly changing landscape?

In this webinar, brought to you by Syneos Health, experts in clinical trial technology, design, and execution will come together in a moderated discussion to explore these different facets of the opportunities created by AI, both traditional and generative.

Join us on Monday, 5th February at 9am CST, 3pm GMT, 4pm CET as panellists unpack what’s new in the industry, exploring current perspectives surrounding AI and ML in clinical trials, disruptive and incremental use cases, outstanding challenges, and how sponsors can navigate a rapidly advancing technology landscape. This webinar will also explore:

  • AI use cases and applications in clinical trials
  • Tips, tricks, and things to watch out for in AI implementations
  • What could be coming up in the future

Attendees will leave with a better understanding of both the benefits and challenges of AI and ML in clinical research, and how to begin moving forwards in their own organisation.

About the panel

Bob ZambonBob Zambon

Dr Zambon is Vice President, Technology Strategy & Strategic Partnerships, at Syneos Health. In his role, Dr Zambon leads and supports the development and operationalisation of strategic solutions for Syneos Health customers to help address their key R&D and commercial needs by integrating data, technology, analytics, and various partnerships into approaches that accelerate and advance their most important development programs.

Dr Zambon has over twenty years of experience in the life sciences industry, with experience in data science, strategy development, clinical research, product development, sales force training, client management, regulatory affairs, analytics, and market research. He’s led and supported innovative research programmes, including pragmatic, decentralised, and siteless studies, in the areas of cardiology, orthopaedics, immunology, infectious disease, and various medical countermeasures.

Dr Zambon received his PhD in Molecular & Cell Biology at the University of Maryland and his BSc in Biotechnology at Rutgers University.

Terttu HaringTerttu Haring, MD

Terttu Haring, MD, is President, Clinical Sites & Patients at Syneos Health. In her role, Dr Haring leads the global clinical operations organisation to drive exceptional delivery, quality, and data integrity for customers, while ensuring a positive experience for sponsors, sites, and patients.

Dr Haring has over 25 years of experience in the clinical development ecosystem, having seen clinical trials from several angles in a research site, large pharma, and CRO setting, including as an investigator and as a research director; by managing local and regional teams in the Netherlands, Europe & Africa; and through overseeing global trial operations and data management activities and pushing digital innovations to clinical operations.

Dr Haring received her MD from Maastricht University in the Netherlands and is based out of the Syneos Health office in Amsterdam.

Jonah ComstockJonah Comstock, editor-in-chief at pharmaphorum (moderator), is a veteran digital health journalist. An early hire at MobiHealthNews, he most recently led editorial efforts at HIMSS Media.

* When you click to register for this webinar you will be taken to a website run by BrightTalk who host the webinar and gather your registration data.
This data may then be passed to pharmaphorum media limited, and in turn passed to the company(ies) we are partnering with to bring you the webinar. This data may be used by us and them for occasional marketing purposes. It will not be shared with any further third parties.
By clicking to register for this webinar you give consent for any data you provide to be used in this way.
If at any point you no longer wish to be contacted based on the information you provide during the registration for this webinar, please send an email to requesting that your information is deleted in accordance with the General Data Protection Regulation.

Originally Appeared Here

You May Also Like

About the Author:

Early Bird